Marker for differential diagnosisA new marker useful for differential diagnosis of cholangiocarcinoma (CC) from hepatocellular carcinoma (HCC) has been identified and investigated. cDNA clone for S100A6 (calcyc
The diagnosis is unlikely to be made based on laboratory tests alone 1. However, the addition of bedside ultrasound, particularly for the evaluation of gallbladder pathology, is both rapid and reliable 2-8. The algorithm below provides a pathway for the incorporation of bedside ultrasound of the...
To estimate the diagnostic accuracy of the sum of relative enhancement ratio (sRER) in making a differential diagnosis of hepatocellular carcinoma (HCC) from benign cirrhosis-related nodules. Materials and Methods Eighteen benign cirrhosis-related nodules and 18 HCCs were evaluated. Three radiologists ...
Patient case report forms were used to abstract medical records for demographic and clinical information. Information on diagnosis of HCC, viral hepatitis, and non-viral hepatitis, and their treatments was obtained by review of laboratory, pathological, radiological, and clinical records. Non-viral dis...
Upon return, the patient’s mental status worsened associated with hypotension and he was intubated for airway protection and received systemic thrombolysis. He was subsequently taken for emergent endovascular treatment of massive pulmonary embolus. An Algorithm for the Differential Diagnosis of Hypoxemia ...
proliferation (URGCP)89,90and phosphoglycerate mutase 2 (PGAM2;for more details see SupplementSect. 4)91. When comparing the interaction frequencies of HepG2 cells and HCC decreased signal intensities were observed (Fig.4A, comparison between TAD interaction frequency in HepG2-top and HCC-bottom...
was repeated re sulting in a re.diagnosis of HC C , at wh ich point sorgical re sec tion was p erformed . D I SC U S S10 N In a cirrhoti c l iver , vari ous types of hep atocyt ic nodular l esions , ranging from regenera tive nod ules , A HN to HCC , are ...
We evaluated the use of tumor vessel patterns observed during arterial-phase contrast-enhanced ultrasonography (US) to differentiate regenerative nodules (RN) from early hepatocellular carcinoma (HCC) or high-grade dysplastic nodules (HGDN) in patients with chronic liver disease. Pathologically confirmed ...
Objectives To develop a novel diagnostic model combining bilirubin, protein induced by vitamin K absence or antagonist-II (PIVKA-II), and alpha-fetoprotein (AFP) to improve hepatocellular carcinoma (HCC) diagnosis. Methods The serum levels of PIVKA-Ⅱ, A
The quantitative evaluation of contrast harmonic imaging in the differential diagnosis of hepatic tumors and the therapeutic effect of hepatocellular carcinoma (HCC) with B-mode second harmonic ultrasonography: Naoki Hori, Saiseikai Kyoto Hospital, Nagaokakyo, Kyoto Japan; Motonari Sakai, Saiseikai Kyoto...